Volume 13, Issue 2 (2-2015)                   IJRM 2015, 13(2): 61-70 | Back to browse issues page

XML Persian Abstract Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Bazarganipour F, Taghavi S A, Montazeri A, Ahmadi F, Chaman R, Khosravi A. The impact of polycystic ovary syndrome on the health-related quality of life: A systematic review and meta-analysis. IJRM. 2015; 13 (2) :61-70
URL: http://journals.ssu.ac.ir/ijrmnew/article-1-621-en.html
1- Hormozgan Fertility and Infertility Research Center, Hormozgan University of Medical Sciences, Bandarabbas, Iran
2- Mental Health Research Group, Health Metrics Research Center, Iranian Institute for Health Sciences Research, ACECR, Tehran, Iran
3- Department of Nursing, Tarbiat Modares University, Tehran, Iran
4- Department of Social Medicine, School of Medicine, Yasuj University of Medical Sciences, Yasuj, Iran
5- Center for Health Related Social and Behavioral Sciences Research, Shahroud University of Medical Sciences, Shahroud, Iran , khosravi2000us@yahoo.com
Abstract:   (6037 Views)
Background: Polycystic ovary syndrome (PCOS) has been shown to cause a reduction in health-related quality of life (HRQOL). However, the relative degree of impairment in each domain differed among samples, and it was not clear which aspect of disease-specific HRQOL (modified polycystic ovary syndrome health-related quality of life questionnaire) was most negatively affected.
Objective: To systematically review the effects of PCOS on specific domains of HRQOL.
Materials and Methods: Literature search using search engine of database (PubMed, PsychInfo, CINAHL, CENTRAL, and Scopus) between 1998 to December 2013 yields 6 relevant publications. Pairs of raters used structural tools to analyze these articles, through critical appraisal and data extraction. The scores of each domain of polycystic ovarian syndrome questionnaire (PCOSQ) or modified version (MPCOSQ) of 1140 women with PCOS were used in meta-analysis.
Results: The combine mean of emotional (4.40; 95% CI 3.77-5.04), infertility (4.13; 95% CI 3.81-4.45) and weight (3.88; 95% CI 2.33-5.42) dimensions were better, but menstruation (3.84; 95% CI 3.63-4.04) and hirsutism (3.81; 95% CI 3.26-4.35) domains were lower than the mean score of PCOSQ/MPCOSQ in related dimension.
Conclusion: The meta-analysis showed that the most affected domains in specific HRQOL were hirsutism and menstruation. Based on these findings, we recommend healthcare providers to be made aware that HRQOL impairment of PCOS is mainly caused by their hirsutism and menstruation, which requires appropriate management.
Full-Text [PDF 737 kb]   (340 Downloads) |   |   Full-Text (HTML)  (133 Views)  
Type of Study: Original Article |

1. World Health Organization.Preventing chronic diseases: a vital investment. Available at: WHO Global Report. 2005;URL: http://www.who.int/ chp/chronic_disease_report/en/.
2. López ED, Eng E, Randall-David E, Robinson N. Quality of life concerns of AfricanAmerican breast cancer survivors within rural North Carolina: blending the techniques of photo -voiceand grounded theory. Qual Health Res 2005; 15: 99-115. [DOI:10.1177/1049732304270766]
3. Ehrmann DA. Polycystic ovary syndrome. N Engl J Med 2005; 352: 1223-1236. [DOI:10.1056/NEJMra041536]
4. Hahn S, Janssen OE, Tan S, Pleger K, Mann K, Chedlowski M, et al. Clinical and psychological correlates of quality-of-life in polycystic ovary syndrome. Eur J Endocrinol 2005; 153: 853-860. [DOI:10.1530/eje.1.02024]
5. Cronin L, Guyatt G, Griffith L, Wong E, Azziz R, Futterweit W, et al. Development of a health-related quality-of-life questionnaire (PCOSQ) for women with polycystic ovary syndrome (PCOS). J Clin Endocrinol Metab 1998; 83: 1976-1987.
6. Guyatt G, Weaver B, Cronin L, Dooley JA, Azziz R. Health-related quality of life in women with polycystic ovary syndrome, a self-administered questionnaire, was validated. J Clin Epidemiol 2004; 57: 1279- 1287. [DOI:10.1016/j.jclinepi.2003.10.018]
7. Jones GL, Benes K, Clark TL, Denham R, Holder MG, Haynes TJ, et al. The polycystic ovary syndrome health-related quality of life questionnaire (PCOSQ): a validation. Hum Reprod 2004; 19: 371-377. [DOI:10.1093/humrep/deh048]
8. McCook J, Reame N, Thatcher S. Health-related quality of life issues in women with polycystic ovary syndrome. J Obstet Gynecol Neonatal Nurs 2005; 34: 12-20. [DOI:10.1177/0884217504272945]
9. Barnard L, Ferriday D, Guenther N, Strauss B, Balen AH, Dye L. Quality of life and psychological well being in polycystic ovary syndrome. Hum Reprod 2007; 22: 2279-2286. [DOI:10.1093/humrep/dem108]
10. Bazarganipour F, Ziaei S, Montazeri A, Foroozanfard F, Faghihzadeh S. Iranian version of modified Polycystic Ovary Syndrome Health-Related Quality of Life Questionnaire: discriminant and convergent validity. Iran J Reprod Med 2013; 11: 753-760.
11. Bazarganipour F, Ziaei S, Montazeri A, Faghihzadeh S, Frozanfard F. Psychometric properties of the Iranian version of modified Polycystic Ovary Syndrome Health-Related Quality of Life Questionnaire. Hum Reprod 2012; 27: 2729-2736. [DOI:10.1093/humrep/des199]
12. Vandenbroucke JP, von Elm E, Altman DG, Gotzsche PC, Mulrow CD, Pocock S, et al. Strengthening the reporting of observational studies in epidemiology (STROBE): explanation and elaboration. PLoS Med 2007; 4: e297. [DOI:10.1371/journal.pmed.0040297]
13. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 2009; 339: b2535. [DOI:10.1136/bmj.b2535]
14. Egger M, Smith GD, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315: 629-634. [DOI:10.1136/bmj.315.7109.629]
15. Cinar N, Harmanci A, Demir B, Yildiz BO. Effect of an oral contraceptive on emotional distress, anxiety and depression of women with polycystic ovary syndrome: a prospective study. Hum Reprod 2012; 27: 1840-1845. [DOI:10.1093/humrep/des113]
16. Cinar N, Kizilarslanoglu MC, Harmanci A, Aksoy DY, Bozdag G, Demir B, et al. Depression, anxiety and cardiometabolic risk in polycystic ovary syndrome. Hum Reprod 2011; 26: 3339-3345. [DOI:10.1093/humrep/der338]
17. Ching HL, Burke V, Stuckey BG. Quality of life and psychological morbidity in women with polycystic ovary syndrome: body mass index, age and the provision of patient information are signifi cant modifi ers. Clin Endocrinol (Oxf) 2007; 66: 373-379. [DOI:10.1111/j.1365-2265.2007.02742.x]
18. Azziz R CE, Dewailly D, Diamanti-Kandarakis E, Escobar-Morreale HF, Futterweit W, Janssen OE, et al. Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline. J Clin Endocrinol Metab 2006; 91: 4237-4245. [DOI:10.1210/jc.2006-0178]
19. Rabinowitz S, Cohen R, Le Roith D. Anxiety and hirsutism. Psychol Rep 1983; 53: 827-830. [DOI:10.2466/pr0.1983.53.3.827]
20. Sonino N, Fava GA, Mani E, Bellurdo P, Boscaro M. Quality of life in hirsuit women. Postgrad Med J 1993; 69: 186-189. [DOI:10.1136/pgmj.69.809.186]
21. Conn JJ, Jacobs HS. Managing hirsutism in gynaecological practice. Br J Obstet Gynaecol 1998: 105: 687-96. [DOI:10.1111/j.1471-0528.1998.tb10197.x]
22. Lanigan S, Kwan C, Dykes P, Gonzales M. Quality of life studies in hirsute women receiving ruby laser treatment. Br J Dermatol 2000; 143: 50.
23. Keegan A, Liao L, Boyle M. Hirsutism: A psychological analysis. J Health Psychol 2003; 8: 327-345. [DOI:10.1177/1359105303008003004]
24. Kitzinger C, Willmott J. The thief of womanhood': women's experience of polycystic ovarian syndrome. Soc Sci Med 2002; 54: 349-361. [DOI:10.1016/S0277-9536(01)00034-X]
25. Sonino N, Fava GA, Mani E, Belluardo P, Boscaro M. Quality of life of hirsute women. Postgrad Med J 1993; 69: 186-189. [DOI:10.1136/pgmj.69.809.186]
26. Shulman LH, Derogatis L, Spielvogel R, Miller JL, Rose LI. Serum androgens and depression in women with facial hirsutism. J Am Acad Dermatol 1992; 27: 178-181. [DOI:10.1016/0190-9622(92)70166-D]
27. Elsenbruch S, Benson S, Hahn S, Tan S, Mann K, Pleger K, et al. Determinants of emotional distress in women with polycystic ovary syndrome. Hum Reprod 2006; 21: 1092-1099. [DOI:10.1093/humrep/dei409]
28. Schmid J, Kirchengast S, Vytiska-Binstorfer E, Huber J. Infertility caused by PCOS-health-related quality of life among Austrian and Moslem immigrant women in Austria. Hum Reprod 2004; 19: 2251-2257. [DOI:10.1093/humrep/deh432]
29. de Niet JE, de Koning CM, Pastoor H, Duivenvoorden HJ, Valkenburg O, Ramakers MJ, et al. Psychological well-being and sexarche in women with polycystic ovary syndrome. Hum Reprod 2010; 25: 1497-1503. [DOI:10.1093/humrep/deq068]
30. Omran AR. Family Planning in the Legacy of Islam. London:Routledge. 1992.
31. Gottlieb A. Sex, fertility and menstruation among the Beng of the Ivory Coast: A symbolic analysis. Africa (Lond) 1982; 52: 3447-3466. [DOI:10.2307/1160093]

Send email to the article author

© 2021 All Rights Reserved | International Journal of Reproductive BioMedicine

Designed & Developed by : Yektaweb